Cam Gallagher

Cam Gallagher

Former President, Interim Chief Financial Officer and Interim TreasureratZentalis Pharmaceuticals· In proxies 2022–2024

Pay in FY2024-32% from the year before · Zentalis Pharmaceuticals stock -80.0% the same year

Cam Gallagher was paid $5.8M in FY2024 (Dec), down 32%. Zentalis Pharmaceuticals stock fell 80.0% that year.

Pay$100 in the stock at the end of FY21 → $4
Pay is from the Summary Compensation Table of each Zentalis Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Zentalis PharmaceuticalsPublic company · 4 yr
    • Former President, Interim Chief Financial Officer and Interim Treasurer2022 – Present · 4 yrStock in role -97%
  2. Ocuphire Pharma, Inc.Public company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years
  3. UC San Diego HealthPublic company · 7 yr
    • Director2019 – Present · 7 yrNo stock prices for these years
  4. VelosBio Inc.Public company · 9 yr
    • Director2017 – Present · 9 yrNo stock prices for these years
  5. Healios K.K.Public company · 1 yr
    • Director2022 – 2023 · 1 yrNo stock prices for these years
  6. Ray Therapeutics, Inc.Public company · 2 yr
    • Director2021 – 2023 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?